Close

Articles Posted in Product Liability

Updated:

Lilly, Amylin Disclose More Cases of Byetta-Related Pancreatitis

Last week, the FDA said it had received reports of six new cases of pancreatitis – including two deaths – associated with the diabetes drug Byetta. Today, Amylin and Eli Lilly said that they had reported four additional deaths to the agency as well, which the FDA hasn’t yet made…

Updated:

FDA Receives 2 Reports of Death, 4 More Hospitalizations in Patients Using Type 2 Diabetes Drug Byetta

The FDA today said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users. Those patients had hemorrhagic pancreatitis (inflammation of the pancreas with bleeding) or necrotizing pancreatitis (in which…

Updated:

FDA and Byetta Pancreatitis Side Effects

Byetta is an injectable therapy to improve blood sugar control in patients with Type II diabetes, which is most often prescribed for patients who have not been able to achieve adequate control on metformin and/or a sulfonylurea, two often prescribed diabetes medications that are taken orally. Byetta has been prescribed…

Updated:

Defective Drugs: Digitek Lawsuits

Two months after a Digitek recall was issued due to manufacturing problems that allowed double strength tablets to be commercially released, at least three lawsuits have been filed. A number of additional cases are expected to be filed in the coming weeks, as hundreds of potential cases are currently being…

Updated:

Chantix Litigation

Chantix the anti smoking drug, has been linked to an increased risk of psychiatric and mental health problems including suicides, suicide attempts, aggressive and unusual behavior. The FDA has received many reports involving serious and sometimes fatal injuries linked to Chantix to psychiatric side effects. Lawsuits have been filed on…

Contact Us
Start Chat